Greater Access to Affordable Pharmaceuticals Act of 2002

The Greater Access to Affordable Pharmaceuticals Act of 2002 aims to lower prescription drug costs by accelerating the entry of generic medications into the marketplace and allowing the importation of drugs from Canada. The bill would reform the patent litigation process to prevent brand-name drug manufacturers from using repeated legal delays to block generic competitors, while also establishing a system for pharmacists and wholesalers to safely import U.S.-made medications from Canada at lower prices. Additionally, the legislation provides financial relief to states by allowing them to negotiate drug rebates for non-Medicaid residents and increasing federal funding for state healthcare programs.